Secukinumab 300mg s.c.

DRUG2 trials

Sponsors

Tongji Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Ankylosing Spondylitis (AS)Moderate-to-severe Plaque PsoriasisOverweight , ObesityPlaque PsoriasisPsoriasis

Phase 4

A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

RecruitingNCT05303285

Tongji HospitalAnkylosing Spondylitis (AS)

Start: 2024-06-14End: 2026-08-31Target: 100Updated: 2026-01-27

Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients

Not yet recruitingNCT07485764

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyModerate-to-severe Plaque Psoriasis, Overweight , Obesity, Plaque Psoriasis +1

Start: 2026-06-01End: 2029-06-01Target: 186Updated: 2026-03-25